Past Support
Director
Adrianna Vlachos, MD
Co-Director
Jeffrey M. Lipton, MD, PhD
Investigator
Alexandra Satty, MD
Manager, Clinical Research
Eva Atsidaftos, MA, CCRA
Senior Clinical Research Coordinator
Maryam Hussain, MPH
National Heart, Lung, and Blood Institute/National Institutes of Health
Department of Defense
Diamond Blackfan Anemia Foundation
ASH Bridge Grant
OUR MISSION STATEMENT
The mission of the DBAR is to be an essential tool for the investigation of the epidemiology and biology of DBA and the conduct of therapeutic trials.
Diamond Blackfan Anemia Syndrome (DBAS)
DBAS is an extremely rare, severe anemia of childhood. It is estimated that there are only 20-40 new cases per year in the United States and Canada. Because of the rarity of this disorder there are gaps in the understanding of its natural history. For this reason, the Diamond Blackfan Anemia Registry (DBAR) of North America was established in 1991 to collect accurate clinical and demographic data on patients with DBAS and their families. The DBAR is a research organization dedicated to acquiring, analyzing and disseminating information on Diamond Blackfan anemia syndrome to affected individuals, their families and medical professionals. The DBAR has collected information over 850 patients in its database.
• The DBAR collects confidential data on patients with DBAS in the US, Canada, and Mexico.
• Patients are enrolled with the help of their hematologists and other physicians (internists and pediatricians).
• After signed informed consent is obtained from the patient (or his/her parent, if the patient is a minor), the patient is enrolled in the DBAR.
• The patient (or his/her parent) completes a detailed questionnaire, with the help of their physician(s).
• Additional information is obtained with the help of medical records, laboratory results and pathology reports and periodic telephone interviews.
• Family members are asked to respond on behalf of previously enrolled, deceased individuals.
• The DBAR also conducts clinical trials and may collect blood and bone marrow for scientific trials. These are obtained with consent, separate from the DBAR consent.